96707 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being neutral and aliphatic
Sub-classes:PEPTIDE-CONTAINING COMPOSITION
#2PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME
#3METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
#4MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#5BRONCHIAL EMBOLIZATION MATERIAL
#6Cyclic peptide compound simulating natural product structure, and method for preparation thereof
#7HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
#8Inhibitors of IAP
#9PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#10MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#11METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
#12Methods of preparing cytotoxic benzodiazepine derivatives
#13Peptide inhibitors of tight junction permeability
#14MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#15METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES
#16Methods of preparing cytotoxic benzodiazepine derivatives
#17Compounds
#18Inhibitors of IAP
#19Neuropeptide S receptor (NPSR) agonists
#20Methods of preparing cytotoxic benzodiazepine derivatives
#21Methods of preparing cytotoxic benzodiazepine derivatives
#22Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#23CHIRAL COMPOUNDS OF VARYING CONFORMATIONAL RIGIDITY AND METHODS OF SYNTHESIS
#24Methods of preparing cytotoxic benzodiazepine derivatives
#25Inhibition of gliadin peptides
#26Indoline compounds as granzyme B inhibitors
#27INHIBITION OF GLIADIN PEPTIDES
#28Thieno-indole moieties and methods of treating using the same
#29Methods of preparing cytotoxic benzodiazepine derivatives
#30Methods of preparing cytotoxic benzodiazepine derivatives
#31Methods of preparing cytotoxic benzodiazepine derivatives
#32Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#33HCV protease inhibitors and uses thereof
#34Inhibitors of IAP
#35Indoline compounds as granzyme B inhibitors
#36HCV NS3 protease inhibitors
#37Peptides having NF-κB inhibitory activity, or composition comprising same
#38Hepatitis C virus inhibitors
#39INHIBITION OF GLIADIN PEPTIDES
#40HCV protease inhibitors and uses thereof
#41Hepatitis C virus inhibitors
#42Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#43Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
#44Thieno-indole moieties and methods of treating using the same
#45Bifunctional peptide
#46Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity
#47HCV NS3 protease inhibitors
#48Chiral oligomeric pentenoate amides as bio-oligomer mimetics
#49Inhibitors of IAP
#50Versatile native chemical ligation technologies
#51Hepatitis C virus inhibitors
#52Crystaline forms of HCV inhibitor
#53HCV protease inhibitors and uses thereof
#54Hepatitis C virus inhibitors
#55Antiviral compounds
#56HCV protease inhibitors and uses thereof
#57Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#58NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#59Macrocyclic inhibitors of hepatitis C virus replication
#60Antiviral compounds
#61HCV protease inhibitors and uses thereof
#62Macrocyclic hepatitis C serine protease inhibitors
#63Hepatitis C virus NS3 protease inhibitors
#64NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#65Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
#66Inhibiting tumor cell invasion, metastasis and angiogenesis
#67HEPATITIS C INHIBITOR COMPOUNDS
#68Inhibition of gliadin peptides
#69Inhibitors of IAP
#70METHOD FOR PREPARING MACROCYCLES
#71HCV protease inhibitors
#72Inhibitors of serine proteases
#73NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#74Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same
#75NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#76HCV protease inhibitors
#77HCV NS3 protease inhibitors
#78MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS
#79Hepatitis C Virus Inhibitors
#80Organic Compounds and their uses
#81Anti-viral compounds
#82DIMERIC IAP INHIBITORS
#83HCV NS3 Protease Inhibitors
#84Hepatitis C virus inhibitors
#85HCV protease inhibitors and uses thereof
#86HCV protease inhibitors and uses thereof
#87HCV protease inhibitors and uses thereof
#88Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
#89Hepatitis C virus inhibitors
#90MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
#91HCV PROTEASE INHIBITORS
#92Hepatitis C virus inhibitors
#93Phosphonyl ester conjugates as prodrugs
#94Antiviral compounds
#95Antiviral compounds
#96Inhibiting tumor cell invasion, metastasis and angiogenesis
#97NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#98Process for making macrocyclic oximyl hepatitis C protease inhibitors
#99Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
#100Tetrazolyl macrocyclic hepatitis C serine protease inhibitors
#101MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
#102MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
#103MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
#104Antiviral compounds
#105Arylalkoxyl hepatitis C virus protease inhibitors
#106INHIBITORS OF SERINE PROTEASE, PARTICULARLY HCV NS3-NS4A PROTEASE
#107Macrocylic oximyl hepatitis C protease inhibitors
#108Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
#109Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#110Inhibitors of Hepatitis C Virus
#111Inhibitors of hepatitis C virus
#112Inhibitors of Hepatitis C Virus
#113Phosphorus-containing hepatitis C serine protease inhibitors
#114TRIAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#115Macrocylic oximyl hepatitis C protease inhibitors
#116Macrocyclic oximyl hepatitis C protease inhibitors
#117Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same
#118Peptides as NS3-serine protease inhibitors of hepatitis C virus
#119Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
#120Inhibitors of serine proteases
#121Hepatitis C virus inhibitors
#122Hepatitis C virus inhibitors
#123Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
#124Anti-inflammatory peptides
#125Macrocyclic inhibitors of hepatitis C virus replication
#126Peptides as NS3-serine protease inhibitors of hepatitis C virus
#127Asymmetric dosing methods
#128Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
#129Cidofovir peptide conjugates as prodrugs
#130Process for preparing macrocyclic HCV protease inhibitors
#131Ring-closing metathesis process in supercritical fluid
#132Macrocyclic compounds as inhibitors of viral replication
#133Process of removing transition metals
#134Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#135Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
#136Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#137Process for preparing macrocyclic compounds